CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

Pharmaceutical Technology
Original article

China’s NMPA clears Foresee’s Camcevi 42 mg for prostate cancer

Related Companies

Read the original article

Published by Pharmaceutical Technology on October 13, 2026 9:27 AM

Read Original